Search the Newsreel

Price to earnings ratio of PACGOLD LIMITED – ASX:BH6

Is Weaker Q2 Results And New ESOP Shelf Registration Altering The Investment Case For Carlyle Group (CG)?

PACGOLD LIMITED Financial Statements – ASX:BH6

PACGOLD LIMITED Earnings and Revenue – ASX:BH6

McGraw Hill (MH) Stock Slips As Profit Rebound Meets K 12 Doubts

McGraw Hill's stock (MH) fell by 3.5% despite Q1 2027 results showing a significant rebound to profitability with basic EPS of US$0.30 and net income of US$57.9m. While the company demonstrated progress in recurring and digital revenue, bears remain concerned about the slow growth …

McGrath RentCorp (MGRC) VP reallocates 6,077 shares in employee stock plan

McGrath RentCorp VP John P. Skenesky reallocated 6,077 shares of common stock held indirectly through the company's Employee Stock Ownership and 401(k) Plan. This "other" disposition (code J) on August 12, 2026, was a diversification election, with proceeds remaining within the plan. Following the …

CG Oncology (CGON) sees Foresite Capital report 4.9% beneficial stake via funds

Foresite Capital funds and James B. Tananbaum have reported beneficial ownership in CG Oncology (CGON) via a SCHEDULE 13G/A filing. While individual funds hold stakes under 5%, James B. Tananbaum, managing member of the involved Foresite Capital entities, is deemed to beneficially own 4,306,174 …

AllianceBernstein reports 6.2% stake in Commercial Bancgroup Inc (CBK)

Insider Buying: Centerra Gold (TSE:CG) Director Buys C$29,760.00 in Stock

McGraw Hill (NYSE:MH) Stock Price Down 6.3% - What's Next?

McGrath RentCorp VP Skenesky sells $240,820 in company shares

John P. Skenesky, VP and Division Manager at McGrath RentCorp (NASDAQ:MGRC), sold 2,000 shares of common stock for $240,820 on August 11, 2026. This transaction leaves him with 10,634 shares. The company recently reported second-quarter 2026 earnings that missed Wall Street expectations, though it …

Sell Alert: Philip B Hawkins Cashes Out $536K In McGrath RentCorp Stock

Carlyle, CVC Team Up to Bid for Security Systems Group Bauwatch

Carlyle Group Inc. and CVC Capital Partners Plc are reportedly exploring a joint bid to acquire security systems provider Bauwatch. The private equity consortium is in discussions with Bauwatch's current owner, Franz Haniel & Cie GmbH, a German family holding company, regarding the potential …

Earnings To Watch: DocGo Inc (DCGO) Q2 2026 -- GF Value Sees 151% Upside

DocGo Inc (DCGO) is scheduled to release its Q2 2026 earnings on August 17, 2026, with revenue estimated at $75.4 million and an expected loss of $0.06 per share. Analysts have an average target price of $1.88, suggesting a 187.05% upside from the current …

These Analysts Revise Their Forecasts On McGraw Hill After Q1 Results

CG Oncology (CGON): RTW Investments takes 9.7% position, holding 8.5M shares

RTW Investments, LP and Roderick Wong, M.D. have reported a 9.7% beneficial ownership in CG Oncology, Inc. (CGON), totaling 8,514,590 common shares. These shares are held by RTW-managed funds, with RTW Investments and Dr. Wong sharing voting and dispositive power. The ownership percentage is …

McGraw Hill, Inc. 2027 Q1 - Results - Earnings Call Presentation (NYSE:MH) 2026-08-14

McGraw Hill reported stronger-than-expected Q1 fiscal 2027 results, with revenue up 2.6% to $550 million and recurring revenue increasing nearly 10%. The company reaffirmed its full-year guidance, driven by growth in Higher Education and K-12, the latter benefiting from science-of-reading mandates. McGraw Hill also …

Kip McGrath (ASX:KME)swings back to profit

CG Oncology's bladder cancer drug shows strong results with 75% response rate and no severe side effects.

CG Oncology's experimental drug cretositimogene grenadenorepvec (cret) has shown promising results in treating non-muscle invasive bladder cancer (NMIBC), achieving a 75% complete response rate and demonstrating a best-in-class safety profile with no severe adverse events. The company plans to submit a Biologics License Application …

CG Oncology Stock: Circling Back After Huge Rally (NASDAQ:CGON)

McGrath RentCorp (NASDAQ:MGRC) CEO Philip Hawkins Sells 4,435 Shares of Stock

McGrath RentCorp (NASDAQ:MGRC) CEO Philip Hawkins sold 4,435 shares of company stock on August 11th, reducing his direct ownership by 24.91% to 13,371 shares, valued at $1,616,687.61. The sale, at an average price of $120.91 per share, generated $536,235.85. This transaction comes as McGrath …

McGrath RentCorp (NASDAQ:MGRC) VP John Skenesky Sells 2,000 Shares

McGrath RentCorp VP John Skenesky sold 2,000 shares of MGRC stock for a total of $240,820, reducing his position by 15.83%. This sale comes after the company reported quarterly earnings that missed analyst expectations, with adjusted EPS of $1.37 against a $1.47 consensus and …

McGrath RentCorp (MGRC) CEO Hawkins sells 4,435 shares in open-market trades

McGrath RentCorp CEO Philip B. Hawkins sold a total of 4,435 shares of company common stock in open-market trades on August 11, 2026. This included a main block of 4,430 shares at a weighted average price of $120.911 and an additional 5 shares at …

Could Centerra Gold (TSX:CG) Keep Reaching New Highs?

CGON (CGON) investor lists 25,989-share sale after series of stock disposals

An investor in CG Oncology, Inc. (CGON) has filed a Form 144, indicating a planned sale of 25,989 common shares with an aggregate market value of $1,973,970.86, expected on August 13, 2026. This filing also discloses a series of prior open-market sales by Ambaw …

CG Oncology (CGON): Wellington group discloses 5.3M-share, 6.04% ownership position

A group of affiliated Wellington entities has disclosed a beneficial ownership of 5,324,751 shares of CG Oncology (CGON) common stock, representing 6.04% of the class. This disclosure, filed via a SCHEDULE 13G/A, indicates shared voting power over 4,637,354 shares and shared dispositive power over …

Carlyle Group (CG) Q2 2026 Earnings Report - Results, Call & Slides

McGraw Hill Releases Q1 2027 Financial Results

McGraw Hill, Inc. (MH) reported strong first-quarter 2027 financial results, exceeding Wall Street expectations with adjusted diluted earnings of $0.59 per share and revenue of $549.9M. The company's K-12 segment showed growth, and its stock holds a favorable view among analysts. The results highlight …

Earnings call transcript: McGraw Hill tops Q1 2026 EPS estimates, shares jump 12%

McGraw Hill reported strong first-quarter fiscal 2027 results, surpassing EPS and revenue estimates, driven by growth in recurring revenue, digital adoption, and disciplined cost control. The company's shares jumped 12% following the report, with management reaffirming full-year guidance and highlighting strategic investments in AI …

McGraw Hill (NYSE:MH) Shares Gap Up on Better-Than-Expected Earnings

CG Oncology (CGON) Faces A Fair Value Gap Following Its Latest Earnings

CG Oncology recently reported its Q2 and H1 2026 earnings, showing revenue of US$1.16 million for the quarter and a net loss of US$79.06 million. Despite being a loss-making company, a discounted cash flow (DCF) model by Simply Wall St estimates a fair value …

What Is Behind Centerra Gold’s (TSX:CG) Latest Market Move?

McGraw Hill Shares Rise Nearly 4% After Q1 Earnings and Revenue Beat Forecasts